Breakthrough T1D Advocacy

05/22/2026

We applaud Representatives Congresswoman Kim Schrier (D-WA) and Congressman John Joyce (R-PA) and Senator Jeanne Shaheen (D-NH) and Senator Susan Collins (R-ME) for introducing the Strengthening Collective Resources for Encouraging Education Needed (SCREEN) for Type 1 Diabetes (T1D) Act of 2026. The bipartisan legislation aims to increase awareness and improve early detection of T1D.

Screening and early detection of T1D can save lives, help people make important decisions about their health, and potentially change the course of this disease.

Too often, children and adults are diagnosed only after becoming critically ill. Screening for T1D can be done through a simple blood test, and ongoing monitoring can help families avoid medical emergencies and take action sooner.

Swipe to learn more and visit the link below to take action!

https://www2.breakthrought1d.org/site/Advocacy?page=UserAction&cmd=display&id=647

05/20/2026

Another step forward! Our champions and Congressional Diabetes Caucus Co-Chairs Congresswoman Diana DeGette and Congressman Gus Bilirakis just sent a letter to the FDA noting our HHS proposal and urging a new look at the regulatory pathway for deceased donor islets.

These islets can help people with type 1 diabetes today. The pathway needs to catch up, and we'll keep pushing until it does.

Thank you to our champions in the House!

05/08/2026

Thank you, Elise, former Breakthrough T1D Children's Congress delegate and current Young Adult Advocacy Council member, for sharing your story, and Senator Jeanne Shaheen, for your leadership on the bipartisan INSULIN Act. We urge the Senate to pass it to take additional steps to make insulin more affordable.

05/07/2026

Thank you, Senator Jeanne Shaheen, for your leadership on insulin affordability. Breakthrough T1D is proud to support the bipartisan INSULIN Act, which builds on recent progress to reduce insulin costs. We urge the Senate to move swiftly to advance it.

04/25/2026

As comes to a close, we want to extend a final ‘thank you’ to all of our Breakthrough T1D Advocacy volunteers across the county who fight tirelessly to secure Federal funding for research, improve access and affordability, and drive toward cures!

With your dedication and commitment, we are and powering T1D breakthroughs together!

04/25/2026

🏛️Advocacy in Action

Bryce became involved with Breakthrough T1D Advocacy to use his voice to create real change — and he got to see these efforts come to life last month in Washington, D.C. While on the Hill, in addition to thanking Congress for extending and increasing the Special Diabetes Program, Bryce informed his U.S. Senators about the INSULIN Act, legislation that was introduced at the end of March to ensure everyone with has affordable access to insulin.

Bryce has personal experience making the impossible choice between buying textbooks for grad school or filling his insulin prescription, so this legislation is particularly important to him. Thank you, Bryce, for using your story to influence lawmakers and create change! Join Bryce in urging your Senators to cosponsor the INSULIN Act today: BreakthroughT1D.org/Advocacy

04/24/2026

04/24/2026

Breakthrough T1D’s Young Adult Advocacy Council (YAAC) represents the next generation of Advocacy volunteers. These young adults actively support the advancement of Breakthrough T1D’s advocacy priority areas, share their stories, and spread awareness of in their communities.

This group, founded in 2023, provides a way for young adults ages 18 - 28 to meaningfully engage in Breakthrough T1D’s advocacy work, while simultaneously bolstering our grassroots volunteer pipeline.

The YAAC are some of our most engaged volunteers and always strive to do more to help the T1D community. Thank you for your commitment and passion!

04/24/2026

For families facing type 1 diabetes (T1D), new scientific advances bring meaningful hope. Annie, who lives with T1D, shares her story as a mother of a 7-year-old son who has T1D autoantibodies and, up until now, had no options for intervention.

With the new U.S. Food and Drug Administration (FDA) approval of Tzield for children ages 1 and up, there is now a therapy that can delay the progression of T1D. This milestone represents a very significant step forward for families like Annie’s—offering more time without needing insulin, which means additional years without the physical, emotional, and financial burdens of this disease.

We applaud the FDA for this approval. This progress moves us closer to cures for T1D.